Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Trial With TMC278-TIDP6-C222 for Continued TMC278 Access in Patients Infected With Human Immunodeficiency Virus-1

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Janssen R&D Ireland
ClinicalTrials.gov Identifier:
NCT01266902
First received: December 23, 2010
Last updated: December 1, 2016
Last verified: December 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 2018
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)